Handelsavisen
prelaunch
Companies Healthcare BMPG.SG
BM
BMPG.SG Pharmaceuticals

B.M.P. Pharma Trading AG

$6,25
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
9,23 %
Op margin
-123 958,8 %
ROE
32,2 %
Net margin
179 972,5 %
Debt / equity
0,01
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

BMPG.SG operates in the Pharmaceuticals industry, focusing on the development and commercialization of pharmaceutical products.

Business. BMPG.SG is a pharmaceutical company engaged in the development and sale of pharmaceutical products. The firm operates within the broader healthcare sector, specifically focusing on pharmaceuticals and medical research activities. Detailed information regarding its operating segments, headquarters location, and primary stock exchange listings is not available in the provided data. Consequently, the company is described at the industry level without specific geographic or segmental breakdowns.

Classification92 %
SectorHealthcare
Business sectorPharmaceuticals & Medical Research
IndustryPharmaceuticals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
32,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning BMPG.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to BMPG.SG. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    BMPG.SG is a pharmaceutical company engaged in the development and sale of pharmaceutical products. The firm operates within the broader healthcare sector, specifically focusing on pharmaceuticals and medical research activities. Detailed information regarding its operating segments, headquarters location, and primary stock exchange listings is not available in the provided data. Consequently, the company is described at the industry level without specific geographic or segmental breakdowns.

    Classification92 %
    SectorHealthcare
    Business sectorPharmaceuticals & Medical Research
    IndustryPharmaceuticals
    AI synthesis
    GENERATED

    BMPG.SG exhibits a strong liquidity position, with a current ratio of 53.44, indicating that the company holds significantly more current assets than current liabilities. However, the company's net cash position is negative after subtracting total debt, which raises concerns about its short-term liquidity. The debt-to-equity ratio is 0.01, suggesting that the company is not heavily leveraged and relies primarily on equity financing.

    In terms of profitability, BMPG.SG has a return on equity (ROE) of 0.3222 and a return on assets (ROA) of 0.2144, both of which are positive but must be compared to industry medians to assess relative performance. The company reported a net income of 2,879,560 EUR, despite an operating loss of -1,983,340 EUR, indicating that non-operating income or gains significantly contributed to profitability.

    The company's revenue is concentrated in a single segment, as no segmental breakdown is provided in the available data. This lack of diversification may expose the company to higher risk if demand for its primary product or service declines. There is no geographic breakdown provided, so it is unclear whether the company is exposed to regional concentration risks.

    Looking at the growth trajectory, the available data does not provide forward-looking revenue projections or historical growth rates. Therefore, it is difficult to assess the company's growth potential or trajectory. The company's operating loss suggests that it may be in an early stage of development or facing operational challenges that could impact future growth.

    The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, suggesting potential liquidity constraints. The low dilution risk implies that the company is not expected to issue additional shares in the near term, which is a positive sign for existing shareholders.

    There are no recent events or filings provided in the available data to inform the company's current strategic direction or operational developments. Without additional information, it is difficult to assess the impact of recent events on the company's financial performance or strategic outlook.

    Key takeaways
    • BMPG.SG has a strong liquidity position with a current ratio of 53.44, but its net cash position is negative after subtracting total debt.
    • The company's ROE of 0.3222 and ROA of 0.2144 indicate positive returns, but these must be compared to industry medians for a full assessment.
    • The company's revenue and geographic exposure are not diversified, as no segmental or geographic breakdown is provided.
    • The company reported a net income of 2,879,560 EUR despite an operating loss of -1,983,340 EUR, indicating significant non-operating income or gains.
    • The risk assessment indicates a medium liquidity risk and a low dilution risk, with no recent events provided to inform strategic developments.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $6,25
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $8.9M
    Net cash
    -$126.0k
    Current ratio
    53.4
    Debt / equity
    0.0
    ROA
    21.4%
    ROE
    32.2%
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-123 958,8 %Bottom quartile
    Net Margin179 972,5 %Best in class
    ROE32,2 %Best in class
    D/E0,01Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Return On Assets
      net_income / total_assets
    Source documents
    • BMPG.SG Market data — financials · 2026-05-27

    Ownership & reference

    Leadership

    • Henning Alfons NauMember of the Management Board
    • Wolfgang WestphalenChairman of the Supervisory Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    BMPG.SGCanonical
    — · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage